not tagged
not tagged
['hodgkin', 'lymphoma']
swiss #biotech is gunning for a second adc approval after reporting ph2 results with cd25-targeting hodgkin lymphoma candidate cami at #eha2022 #oncology 
https://t.co/O0ZJQGMjEP, and its digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate